Average Co-Inventor Count = 5.52
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (49 from 3,685 patents)
2. Pharmacopeia Inc. (2 from 101 patents)
3. Other (1 from 832,880 patents)
4. Bristol-myers Squibb Pharma Company (234 patents)
50 patents:
1. 12492188 - 1H-benzo[D]imidazole derivatives as TLR9 inhibitors for the treatment of fibrosis
2. 12479831 - Substituted N(-methyl-D3)pyridazine-3-carboxamide or M-(methyl-D3)-nicotinamide compounds as IL-12, IL-23 and/or IFNα modulators
3. 12365667 - Sulfone pyridine alkyl amide-substituted heteroaryl compounds
4. 12291522 - Galectin-3 inhibitors
5. 12275719 - Small molecule inhibitors of galectin-3
6. 12269819 - Small molecule inhibitors of Galectin-3
7. 11787779 - Sulfone pyridine alkyl amide-substituted heteroaryl compounds
8. 11597721 - Heterocyclic compounds comprising pyridine useful as modulators of IL-12, IL-23 and/or IFNα responses
9. 11286252 - Alkene spirocyclic compounds as farnesoid X receptor modulators
10. 11168079 - Alkene compounds as farnesoid x receptor modulators
11. 11021462 - Sulfone pyridine alkyl amide-substituted heteroaryl compounds
12. 10273237 - Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN-α responses
13. 10000480 - Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
14. 9987266 - Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
15. 9663467 - Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses